05:26 PM EDT, 08/28/2024 (MT Newswires) -- Phibro Animal Health ( PAHC ) reported fiscal Q4 adjusted earnings late Wednesday of $0.41 per diluted share, up from $0.38 a year earlier.

Three analysts polled by Capital IQ expected $0.33.

Net sales in the three months ended June 30 rose to $273.2 million from $255 million a year earlier. A lone analyst surveyed by Capital IQ expected $260.5 million.

The company expects fiscal 2025 adjusted diluted EPS of $1.22 to $1.37 on net sales of $1.04 billion to $1.09 billion. Three analysts polled by Capital IQ project EPS of $1.24 and two analysts forecast revenue of $1.03 billion.